clopidogrel has been researched along with Endoleak in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dubin, I; Schattner, A; Uliel, L | 1 |
Alonso Pérez, M; Álvarez Marcos, F; Caeiro Quinteiro, S; Franco Meijide, FJ; Llaneza Coto, JM; Vilariño Rico, J; Zanabili Al-Sibbai, AA | 1 |
2 other study(ies) available for clopidogrel and Endoleak
Article | Year |
---|---|
Endoleak-induced DIC presenting as massive chest wall haematoma in a patient on dual antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Disseminated Intravascular Coagulation; Dual Anti-Platelet Therapy; Endoleak; Hematoma; Humans; Male; Platelet Aggregation Inhibitors; Thoracic Wall | 2020 |
Effect of antiplatelet therapy on aneurysmal sac expansion associated with type II endoleaks after endovascular aneurysm repair.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Aneurysm, Abdominal; Aortography; Aspirin; Blood Vessel Prosthesis Implantation; Chi-Square Distribution; Clopidogrel; Computed Tomography Angiography; Contrast Media; Databases, Factual; Drug Therapy, Combination; Endoleak; Endovascular Procedures; Female; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Spain; Ticlopidine; Time Factors; Treatment Outcome | 2017 |